New data show benefit of DaTSCAN™ (Ioflupane I 123 Injection) in the diagnosis of patients with clinically uncertain dementia with Lewy bodies

Data presented at the XXI World Congress of Neurology in Vienna suggest that DaTSCAN™ (Ioflupane I 123 Injection) SPECT imaging could add value to current diagnostic tools used by physicians to diagnose patients with dementia with Lewy bodies (DLB) by improving physician's ability to definitively diagnose the disorder and increase their confidence in so doing. DaTSCAN is GE Healthcare's radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news